Rodman & Renshaw LLC and and MedKnowledge present the latest in a series of medical expert conference calls. Michael G. King, Jr., Senior Biotechnology Analyst, hosts the call featuring:

Ken Fujioka, MD - Director, Nutrition & Metabolic Research Center, Scripps Clinic - Del Mar, San Diego

View From The Boneyard: An Analysis of the Pivotal Trials Presented at ASBMR, Including Denosumab, Lasofoxifene, and Odanacatib

Rodman & Renshaw and Close Concerns present the latest in a series of medical expert conference calls. Michael G. King, Jr., Senior Biotechnology Analyst, hosts the call featuring:

Rodman & Renshaw Capital Group, Inc. (NASDAQ: RODM - News) today announced it has expanded its Energy Research team with the addition of Jason Strominger, further strengthening the firm’s focus on this targeted growth area.

Mr. Strominger joins Rodman as a Vice President and Senior Oil & Gas Analyst where he will focus on both the E&P and Oilfield Services sectors. Mr. Strominger joins Rodman from Credit Suisse where he was a Senior Associate. Prior to this, he worked as an Equity Research Associate at Bear Stearns & Co. Mr. Strominger will reside in Rodman’s New York office.

Rodman & Renshaw Capital Group, Inc. (NASDAQ:RODM - News) today announced that it will hold its Annual Global Investment Conference from November 10-12, 2008 at the New York Palace Hotel, New York City.

“Our Annual Global Investment Conference has always been a premier event on the life science calendar,” said Michael Lacovara, Rodman’s Chief Executive Officer. “We are proud to announce that this year we have expanded the scope to encompass other areas of deep focus for our firm, which include the natural resource and energy sectors, as well as Asia and emerging markets.”

Rodman & Renshaw and Close Concerns present the latest in a series of medical expert conference calls.

The call features:
• Harold E. Lebovitz, MD, Professor of Medicine, Division of Endocrinology and Metabolism/Diabetes
• David G. Orloff, MD, Medical Director / Medical & Regulatory Affairs of Medpace, Inc.

Rodman & Renshaw, LLC, a subsidiary of Rodman & Renshaw Capital Group, Inc. (NASDAQ: RODM - News), today announced the hiring of a senior banker to join its industry-leading healthcare group.

Rodman & Renshaw and Med Knowledge present the latest in a series of medical expert conference calls.

Rodman & Renshaw hosts a conference call, with Michael Lacovara and David Horin, Rodman & Renshaw Capital Group’s Chief Executive Officer and Chief Financial Officer, respectively, discussing the Company's quarterly results.

About Rodman & Renshaw Capital Group, Inc.

Rodman & Renshaw Capital Group, Inc. is a holding company with a number of direct and indirect subsidiaries, including Rodman & Renshaw, LLC, Rodman Principal Investments, LLC and Miller Mathis & Co., LLC.

Reports Record Second Quarter Revenue, up 95% Sequentially

Rodman & Renshaw Capital Group, Inc. (NASDAQ: RODM - News) today announced its results for the second quarter ended June 30, 2008.

Rodman & Renshaw and MedKnowledge present the latest in a series of medical expert conference calls.

The call was hosted by senior biotechnology analysts Elemer Piros, Ph.D. (pictured right) and Raghuram Selvaraju, Ph.D.

Featuring: Lon Schneider, M.D.

Rodman & Renshaw Capital Group, Inc (NASDAQ: RODM - News), today announced that it will release financial results for the quarter ended June 30, 2008 at 8:00 AM Eastern on Tuesday, August 12, 2008. The Company will hold a conference call to discuss the results at 10:00 AM Eastern on Tuesday, August 12, 2008, which will be hosted by Michael Lacovara and David Horin, Rodman & Renshaw Capital Group’s Chief Executive Officer and Chief Financial Officer, respectively.

Rodman & Renshaw Capital Group, Inc (NASDAQ: RODM - News), today announced that its Rodman & Renshaw, LLC subsidiary has maintained its leading position in PIPE transaction deal volume for the first half of 2008, garnering the top spot in PlacementTracker’s First Half 2008 PIPE Market League Tables, published by Sagient Research Systems. During the first half of 2008 Rodman completed 25 transactions raising a total of $404 million. Rodman was the number one ranked PIPE advisor by deal volume for all of 2007 as well.

Rodman & Renshaw, LLC, a subsidiary of Rodman & Renshaw Capital Group, Inc. (NASDAQ: RODM - News) today announced that it has hired three new research analysts to cover the oil and gas and metals and mining sectors.

Jeff Hayden, who will join Rodman as a Managing Director and Senior Oil and Gas Analyst on Monday, July 21 has 10 years of experience in energy research and finance and was formerly associated with Pritchard Capital Partners. Chad Mabry, also formerly associated with Pritchard Capital, will join the firm as an Associate Oil and Gas Analyst on July 21. Both analysts will be resident in Rodman’s Houston office.

Wilfredo Ortiz, who will join Rodman as a Managing Director and Senior Metals and Mining Analyst on August 18, has 12 years of industry experience. Mr. Ortiz, who was most recently a Managing Director at Bear Stearns & Co., was previously an analyst at JPMorgan Chase. Mr. Ortiz will be resident in Rodman’s New York office.

Rodman & Renshaw and Close Concerns present the latest in a series of medical expert conference calls

The call features David G. Orloff, MD, Medical Director / Medical & Regulatory Affairs of Medpace, Inc.

Rodman & Renshaw and MedKnowledge present the latest in a series of medical expert conference calls.

Senior Biotechnology Analyst Michael G. King, Jr. hosts the call, featuring Arthur F. Kavanaugh, MD, Professor of Clinical Medicine, Director, Center for Innovative Therapy, Division of Rheumatology, Allergy and Immunology, University of California, San Diego.

Dr. Arthur Kavanaugh is a Professor of Clinical Medicine and Director at the Center for Innovative Therapy, Division of Rheumatology, Allergy and Immunology at the University of California at San Diego. Dr. Kavanaugh’s research interest include innovative strategies for the treatment of patients with rheumatoid arthritis and other rheumatic diseases, prognostic and predictive factors for outcomes in rheumatic diseases and research programs on approaches to various immunologic diseases, particularly novel biologic therapies. Dr. Kavanaugh has authored dozens of publications in manuscripts, chapters and books.

Rodman & Renshaw and MedKnowledge present the latest in a series of medical expert conference calls.

Senior Biotechnology Analysts Michael G. King, Jr. & Vernon Bernardino host the call, featuring Silvio E. Inzucchi, MD, Professor of Medicine, Section of Endocrinology, Yale University (Clinical Director, Yale-New Haven Hospital, Director of Yale Diabetes Center)

Vernon T. Bernardino, Senior BioTech Analyst at Rodman & Renshaw, hosted a call with Sherwyn L. Schwartz (pictured right), MD, CEO and Chief Medical Officer, Diabetes and Glandular Disease Research Inc., and Giovanni Solinas, PhD, Director of the Laboratory of Medical Stress Biology, Dept. of Medicine, University of Fribourg, Switzerland

Rodman & Renshaw Capital Group, Inc. (NASDAQ: RODM - News), today announced that Ramnarain “Joe” Jaigobind has joined Rodman as Head of Global Capital Markets and President of Middle East, India and Japan markets. Mr. Jaigobind joins Rodman from Maxim Group with a team of eight professionals, significantly strengthening Rodman’s Global Capital Markets practice.

Mr. Jaigobind has significant experience in the public equity markets. He will spearhead Rodman’s initiatives to expand its origination and distribution of initial and secondary public offerings and its participation in syndicated public offerings led by other firms. These enhanced capabilities will complement Rodman’s #1 ranked position in PIPE offerings1, by both broadening the range of capital markets options available to its corporate clients and expanding its investor client base.

Rodman & Renshaw Capital Group, Inc. (NASDAQ: RODM - News), today announced that it has completed the acquisition of COSCO Capital Management LLC and its related companies, a leading private investment bank focused on the oil and gas sectors in the United States and Canada. Rodman previously announced that it had entered into definitive agreements to acquire the COSCO companies on May 12, 2008.